2,213 reports of this reaction
1.4% of all HYDROCODONE BITARTRATE AND ACETAMINOPHEN reports
#13 most reported adverse reaction
DRUG WITHDRAWAL SYNDROME NEONATAL is the #13 most commonly reported adverse reaction for HYDROCODONE BITARTRATE AND ACETAMINOPHEN, manufactured by Amneal Pharmaceuticals LLC. There are 2,213 FDA adverse event reports linking HYDROCODONE BITARTRATE AND ACETAMINOPHEN to DRUG WITHDRAWAL SYNDROME NEONATAL. This represents approximately 1.4% of all 153,212 adverse event reports for this drug.
Patients taking HYDROCODONE BITARTRATE AND ACETAMINOPHEN who experience drug withdrawal syndrome neonatal should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG WITHDRAWAL SYNDROME NEONATAL is a less commonly reported adverse event for HYDROCODONE BITARTRATE AND ACETAMINOPHEN, but still significant enough to appear in the safety profile.
In addition to drug withdrawal syndrome neonatal, the following adverse reactions have been reported for HYDROCODONE BITARTRATE AND ACETAMINOPHEN:
The following drugs have also been linked to drug withdrawal syndrome neonatal in FDA adverse event reports:
DRUG WITHDRAWAL SYNDROME NEONATAL has been reported as an adverse event in 2,213 FDA reports for HYDROCODONE BITARTRATE AND ACETAMINOPHEN. This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG WITHDRAWAL SYNDROME NEONATAL accounts for approximately 1.4% of all adverse event reports for HYDROCODONE BITARTRATE AND ACETAMINOPHEN, making it a notable side effect.
If you experience drug withdrawal syndrome neonatal while taking HYDROCODONE BITARTRATE AND ACETAMINOPHEN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.